Medpace Renews Partnership with SCRS


Ellicott City, MD – The Society for Clinical Research Sites (SCRS) today announced Medpace has extended its commitment as a Global Impact Partner (GIP) by two years. Medpace will continue to serve on the SCRS Global Impact Board at an executive level, and work with the SCRS Leadership Council on strategic initiatives to promote high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.

“When Global Impact Partners renew their partnership with us, they demonstrate their commitment to site sustainability,” said Christine Pierre, president of SCRS. “We are proud of our partnership with Medpace and look forward to our continued collaboration.”

“Medpace is pleased to continue our relationship with SCRS on the Global Impact Board,” said Susan E. Burwig, Medpace Executive Vice President, Operations. “Successful clinical trials rely on a CRO’s access to the best quality investigative sites. Working with other Global Impact Partners allows us to collaborate with industry leaders, producing better solutions for site management and enabling us to continue our reputation of delivering the highest quality studies for our sponsors.”

About Medpace
Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its physician-led, high-science, and disciplined operating approach that leverages regulatory and therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 2,500 people across 35 countries. To learn more, visit

About SCRS
SCRS is a global trade organization founded in 2012 which represents more than 4,000 research sites in 45 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Our Voice. Our Community. Your Success. Join the community and collaborate with the global experts in site sustainability. Visit

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.